title: Should there be mass screening using faecal occult blood tests for colorectal cancer?
authors.affiliation: Registre des Tumeurs Digestives (Equipe associée INSERM-DGS and CRI 9505), Faculté de Médecine, Dijon, France.
authors.forename: J
authors.initials: J
authors.lastname: Faivre
authors.forename: M A
authors.initials: MA
authors.lastname: Tazi
authors.forename: P
authors.initials: P
authors.lastname: Autier
authors.forename: H
authors.initials: H
authors.lastname: Bleiberg
mesh_terms: D016022:Case-Control Studies; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000517:prevention & control; D018849:Controlled Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D016099:Endoscopy, Gastrointestinal; D006801:Humans; D008403:Mass Screening / Q000191:economics / Q000379:methods* / Q000458:organization & administration; D009780:Occult Blood; D012680:Sensitivity and Specificity